|
Sudarshan Pharma Industries Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
697.91 Cr.
|
P/BV
|
6.25
|
Book Value (Rs.)
|
4.64
|
|
52 Week High/Low (Rs.)
|
54/9
|
FV/ML
|
1/4000
|
P/E(X)
|
43.75
|
|
Bookclosure
|
23/11/2024
|
EPS (Rs.)
|
0.66
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.66 | 4.76 | 5.48 | 5.52 | 2.80 |
| Diluted EPS (Rs.) | 0.66 | 4.76 | 5.48 | 5.52 | 2.80 |
| Cash EPS (Rs.) | 0.75 | 5.28 | 3.30 | 6.33 | 3.58 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 5.46 | 46.42 | 41.96 | 30.54 | 23.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 5.46 | 46.42 | 41.96 | 30.54 | 23.63 |
| Revenue From Operations / Share (Rs.) | 20.99 | 192.61 | 191.69 | 366.29 | 202.52 |
| PBDIT / Share (Rs.) | 1.76 | 10.56 | 6.57 | 11.73 | 7.90 |
| PBIT / Share (Rs.) | 1.67 | 10.04 | 6.19 | 10.84 | 7.12 |
| PBT / Share (Rs.) | 0.89 | 6.33 | 3.94 | 7.38 | 3.74 |
| Net Profit / Share (Rs.) | 0.66 | 4.76 | 2.92 | 5.44 | 2.80 |
| NP After MI And SOA / Share (Rs.) | 0.66 | 4.76 | 2.92 | 5.44 | 2.80 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 8.40 | 5.48 | 3.42 | 3.20 | 3.90 |
| PBIT Margin (%) | 7.96 | 5.21 | 3.22 | 2.95 | 3.51 |
| PBT Margin (%) | 4.28 | 3.28 | 2.05 | 2.01 | 1.84 |
| Net Profit Margin (%) | 3.15 | 2.47 | 1.52 | 1.48 | 1.38 |
| NP After MI And SOA Margin (%) | 3.15 | 2.47 | 1.52 | 1.48 | 1.38 |
| Return on Networth / Equity (%) | 12.13 | 10.25 | 6.96 | 17.81 | 11.86 |
| Return on Capital Employeed (%) | 28.18 | 19.76 | 13.06 | 28.97 | 24.25 |
| Return On Assets (%) | 3.96 | 4.04 | 3.02 | 3.85 | 2.69 |
| Long Term Debt / Equity (X) | 0.07 | 0.09 | 0.12 | 0.21 | 0.23 |
| Total Debt / Equity (X) | 1.30 | 0.93 | 0.33 | 0.96 | 1.19 |
| Asset Turnover Ratio (%) | 1.47 | 1.80 | 2.49 | 0.00 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.29 | 1.50 | 1.68 | 1.28 | 1.23 |
| Quick Ratio (X) | 0.74 | 0.96 | 1.05 | 0.81 | 0.89 |
| Inventory Turnover Ratio (X) | 0.07 | 0.07 | 0.01 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 6.30 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 5.68 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 93.70 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 94.32 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.69 | 2.84 | 2.93 | 3.38 | 2.34 |
| Interest Coverage Ratio (Post Tax) (%) | 2.19 | 2.28 | 2.30 | 2.57 | 1.83 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 905.15 | 283.05 | 156.67 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.79 | 0.61 | 0.33 | 0.00 | 0.00 |
| EV / EBITDA (X) | 21.33 | 11.14 | 9.91 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.46 | 0.38 | 0.29 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 93.69 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 5.59 | 1.60 | 1.33 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.46 | 0.38 | 0.29 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.06 | 0.05 | 0.00 | 0.00 |
